Transparency data: Voluntary scheme aggregate net sales and payment information: August 2026

This publication presents transparency data on aggregate net sales and payments for medicines. Specifically, it concerns information for August 2026 within the National Health Service (NHS). The data is part of the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG). The scheme aims to control spending on branded medicines within the NHS. The VPAG scheme is an agreement between the Department of Health and Social Care, NHS England, and the Association of the British Pharmaceutical Industry. Its main objectives include promoting better patient outcomes and a healthier population. Furthermore, it seeks to support UK economic growth and contribute to a financially sustainable NHS. The publication was released on September 22, 2026.